Second Malignancies in Total Therapy 3 Trials for Newly Diagnosed Multiple Myeloma: Influence of Lenalidomide Versus Thalidomide in Maintenance Phases

被引：0
|
作者：
Usmani, Saad [1 ]
Sexton, Rachael [2 ]
Hoering, Antje [2 ]
Heuck, Christoph [1 ]
Nair, Bijay [1 ]
Waheed, Sarah [1 ]
Alsayed, Yazan [1 ]
Petty, Nathan M. [1 ]
Crowley, John [2 ]
Barlogie, Bart [1 ]
机构：
[1] Univ Arkansas Med Sci, Myeloma Inst Res & Therapy, Little Rock, AR 72205 USA
[2] Canc Res & Biostat, Res & Biostat, Seattle, WA USA
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：375 / 375
页数：1
相关论文
共 50 条
  • [1] Second malignancies in total therapy 2 and 3 for newly diagnosed multiple myeloma: influence of thalidomide and lenalidomide during maintenance
    Usmani, Saad Z.
    Sexton, Rachel
    Hoering, Antje
    Heuck, Christoph J.
    Nair, Bijay
    Waheed, Sarah
    Al Sayed, Yazan
    Chauhan, Nabeel
    Ahmad, Nisar
    Atrash, Shebli
    Petty, Nathan
    van Rhee, Frits
    Crowley, John
    Barlogie, Bart
    BLOOD, 2012, 120 (08) : 1597 - 1600
  • [2] Thalidomide, clarithromycin, lenalidomide and dexamethasone therapy in newly diagnosed, symptomatic multiple myeloma
    Mark, Tomer M.
    Bowman, Isaac A.
    Rossi, Adriana C.
    Shah, Manan
    Rodriguez, Melissa
    Quinn, Ryann
    Pearse, Roger N.
    Zafar, Faiza
    Pekle, Karen
    Jayabalan, David
    Ely, Scott
    Coleman, Morton
    Chen-Kiang, Selina
    Niesvizky, Ruben
    LEUKEMIA & LYMPHOMA, 2014, 55 (12) : 2842 - 2849
  • [3] Thalidomide, lenalidomide and bortezomib in the management of newly diagnosed multiple myeloma
    Laubach, Jacob P.
    Schlossman, Robert L.
    Mitsiades, Constantine S.
    Anderson, Kenneth C.
    Richardson, Paul G.
    EXPERT REVIEW OF HEMATOLOGY, 2011, 4 (01) : 51 - 60
  • [4] The incidence of thromboembolism for lenalidomide versus thalidomide in older patients with newly diagnosed multiple myeloma
    Li, Ang
    Wu, Qian
    Warnick, Greg
    Li, Shan
    Libby, Edward N.
    Garcia, David A.
    Lyman, Gary H.
    ANNALS OF HEMATOLOGY, 2020, 99 (01) : 121 - 126
  • [5] The incidence of thromboembolism for lenalidomide versus thalidomide in older patients with newly diagnosed multiple myeloma
    Ang Li
    Qian Wu
    Greg Warnick
    Shan Li
    Edward N. Libby
    David A. Garcia
    Gary H. Lyman
    Annals of Hematology, 2020, 99 : 121 - 126
  • [6] The Incidence of Thromboembolism for Lenalidomide Versus Thalidomide in Older Patients with Newly Diagnosed Multiple Myeloma
    Li, Ang
    Wu, Qian V.
    Warnick, Greg
    Libby, Edward N., III
    Garcia, David A.
    Lyman, Gary H.
    BLOOD, 2018, 132
  • [7] Superiority of Lenalidomide-Dexamethasone Versus Thalidomide-Dexamethasone as Initial Therapy for Newly Diagnosed Multiple Myeloma
    Gay, Francesca
    Hayman, Suzanne
    Lacy, Martha Q.
    Buadi, Francis
    Gertz, Morie A.
    Kumar, Shaji
    Dispenzieri, Angela
    Mikhael, Joseph R.
    Bergsagel, Leif
    Dingli, David
    Reeder, Craig B.
    Lust, John A.
    Russel, Stephen
    Roj, Vivek
    Zeldenrust, Steven R.
    Witzig, Thomas E.
    Fonseca, Rafael
    Kyle, Robert
    Greipp, Philip R.
    Stewart, A. Keith
    Rajkumar, S. Vincent
    BLOOD, 2009, 114 (22) : 1494 - 1495
  • [8] Lenalidomide: A Review in Newly Diagnosed Multiple Myeloma as Maintenance Therapy After ASCT
    Syed, Yahiya Y.
    DRUGS, 2017, 77 (13) : 1473 - 1480
  • [9] Lenalidomide: A Review in Newly Diagnosed Multiple Myeloma as Maintenance Therapy After ASCT
    Yahiya Y. Syed
    Drugs, 2017, 77 : 1473 - 1480
  • [10] Lenalidomide as maintenance for every newly diagnosed patient with multiple myeloma
    Mateos, Maria-Victoria
    Gonzalez de la Calle, Veronica
    LANCET ONCOLOGY, 2019, 20 (01): : 5 - 6
12345